PTC Therapeutics

pharmaceutical company

PTCT Nasdaq ISIN US69366J2006 SEC CIK 1070081 LEI 549300UJLWOIWFDGB318
Follow PTC Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $357.8M +69.6% vs same quarter last year
Net income −$51.7M −425.2% vs same quarter last year
EPS, diluted −$0.62 −410% vs same quarter last year
Operating cash flow −$25.3M +61.8% vs same quarter last year
Revenue by quarter
$213.2M
$1.2B
$178.9M
$211M
$164.7M
$272.6M
$360.5M
$357.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$1.7B$683M
FY24$806.8M−$363.3M
FY23$937.8M−$626.6M
FY22$698.8M−$559M
FY21$538.6M−$523.9M
FY20$380.8M−$438.2M
FY19$307M−$251.6M
FY18$264.7M−$128.1M
FY17$194.4M−$79M
FY16$82.7M−$142.1M
FY15$36.8M−$170.4M
FY14$25.2M−$93.8M
FY13$34.7M−$51.6M
FY12$33.9M-
FY11$105.4M$30.9M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−600%−400%−200%0%200%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-50.1%39.5%
FY24-−37.5%−45%
FY23-−46.9%−66.8%
FY22-−64%−80%
FY21-−69.5%−97.3%
FY20-−113.4%−115.1%
FY1996%−78.6%−82%
FY1895.2%−43.7%−48.4%
FY1797.6%−33.1%−40.6%
FY16100%−159.7%−171.8%
FY15100%−454.6%−463.6%
FY14-−393.8%−371.4%
FY13-−130.8%−148.6%
FY12-−79%-
FY11-29%29.3%
Free cash flowOperating cash flow minus capital expenditure
−$500M$0$500M$1BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$702.3M
FY24−$114.2M
FY23−$186.9M
FY22−$388.7M
FY21−$279.5M
FY20−$211.9M
FY19−$112.4M
FY18−$34.7M
FY17−$13.2M
FY16−$105.3M
FY15−$127.1M
FY14−$61.9M
FY13−$47.8M
FY12−$48.1M
FY11−$20.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • PTC Therapeutics
  • Healthcare median
−600%−400%−200%0%200%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPTC TherapeuticsHealthcare median
FY2539.5%−30.6%
FY24−45%−47%
FY23−66.8%−58%
FY22−80%−80.4%
FY21−97.3%−71.9%
FY20−115.1%−62.2%
FY19−82%−46.3%
FY18−48.4%−49.6%
FY17−40.6%−45.9%
FY16−171.8%−36%
FY15−463.6%−38.4%
FY14−371.4%−35.5%
FY13−148.6%−37.1%
FY12-−29.1%
FY1129.3%−27.9%